- Advertising
- Asia
- Bangladesh
- Biological Inventions
- BRAND VALUATION
- China
- Comparative Advertisement
- Copyright
- Copyright Infringement
- Copyright Litigation
- Counterfeiting
- Covid
- Design
- Digital Marketing Rights
- DRM
- Geographical Indication
- India
- Indian Patents Act
- Indonesia
- Intellectual Property
- Interim Injunction
- IP Commercialization
- IP Licensing
- IP Litigation
- IP Practice in India
- IPAB
- IPAB Decisions
- Japan
- Legal Issues
- Licensing
- Malaysia
- Myanmar
- NCLT
- NEPAL
- Net Neutrality
- News & Updates
- Office
- Patent Commercialisation
- Patent Cooperation Treaty
- patent infringement
- Patent Licensing
- Patent Litigation
- Patent Opposition
- Patent Prosecution
- Patent Rule Amendment
- Patent Term Extension
- Patents
- pharma
- Philippines
- Punitive Damages
- Section 3(D)
- section 64
- Singapore
- South-east Asia
- Technology
- Technology Transfer
- Thailand
- Trademark
- Trademark Litigation
- Uncategorized
- USPTO
- Vietnam
- WIPO
Patent Commercialisation Via Licensing
Intellectual Property refers to creations of the mind such as inventions, expressions in the form of literary and artistic works, symbols, names and images, etc used in commerce. It can further be divided into Industrial Property or Copyright[1]. Patent as a part of Industrial Property is an exclusive right granted for an invention – a … Continue reading Patent Commercialisation Via Licensing
Read more »The Nagoya Protocol – Convention on Biological Diversity
July 21, 2014 - 9:10 am
Categories:
News & Updates
Patent Commercialisation
Patents
Pharma- biotech- Patent Commercialisation
0 Comments
A new international treaty named the “Nagoya Protocol” will be giving some relief to India and other developing countries. The Nagoya Protocol on Access to Genetic Resources with an objective of ensuring access of genetic resources to the signatory countries and ensuring fair and equitable sharing of benefit to the local community and signatory country that … Continue reading The Nagoya Protocol – Convention on Biological Diversity
Read more »Two-Days International Symposium on Strategies for Managing Pharmaceutical, Biotechnology & Chemical Patent Portfolios
December 13, 2013 - 7:42 am
Categories:
Advertising
News & Updates
Pharma- biotech- Patent Commercialisation
0 Comments
We are happy to inform you all that IIPRD and Khurana & Khurana, in association with Cantor Colburn (US) and Fukami Patent Office (Japan) are holding an International Patent Symposium covering all major and relevant Pharmaceutical/Biotechnology Related Patent issues in the month of February, 2014 in India. The Two-Days International Symposium would be covering Strategies for Managing … Continue reading Two-Days International Symposium on Strategies for Managing Pharmaceutical, Biotechnology & Chemical Patent Portfolios
Read more »Technology Transfer/Licensing Opportunity of Crop/Agri Technologies with Syngenta
IIPRD is among the leading Indian IP Consulting Firms focusing on Technology Transfer and Licensing for numerous Indian and Global Corporates and Research Institutes. IIPRD is highly active in the Technology Transfer and Licensing of Patent Backed Technologies/IP’s in the domains of Pharmaceutical, Life Sciences, Diagnostics, Biotechnology, Telecommunications, Software and Medical Devices among others. Syngenta is … Continue reading Technology Transfer/Licensing Opportunity of Crop/Agri Technologies with Syngenta
Read more »NATCO FILES INDIA’S FIRST COMPULSORY LICENSING APPLICATION
September 14, 2011 - 4:38 am
Categories:
Patent Commercialisation
Pharma- biotech- Patent Commercialisation
0 Comments
Natco Pharma has filed India’s first Compulsory Licensing (CL) Application (in accordance with Section 84(1) of the Indian Patents Act) against one of the Bayer’s patented drug Sorafenib, marketed by Bayer as Nexavar for treating Kidney and Liver Cancer. Patent on Sorafenib is granted in India on 03.03.2008 having number IN 215758. This will be … Continue reading NATCO FILES INDIA’S FIRST COMPULSORY LICENSING APPLICATION
Read more »INVENTORS, ALL TECHNOLOGIES AREN’T WORTH BILLIONS
July 31, 2011 - 6:23 pm
Categories:
high-tech-patent-commercialisation
Patent Commercialisation
Pharma- biotech- Patent Commercialisation
0 Comments
Working in the IP/Technology Commercialization and Out-Licensing domain makes you assess and evaluate commercial viability of numerous IP backed inventions across technology domains. Apart from learning about and assessing new technologies, we also tend to learn quite of lot about Inventors mindset, specifically about their perspective of their own inventions. This article relates to our … Continue reading INVENTORS, ALL TECHNOLOGIES AREN’T WORTH BILLIONS
Read more »Anti Cancer drug: Making it Patient-driven, not Disease-driven
April 11, 2011 - 10:16 am
Categories:
Patent Commercialisation
Pharma- biotech- Patent Commercialisation
0 Comments
Introduction: French compatriots Ipsen and bioMérieux, have been few most potential companies, since 2007 in the development of companion assay to assess patient benefit from a compound useful for treating several severe forms of cancers.Partnership between two companies has focused on the two main broad areas of pharma research: Personalized medicine and Theronostics. Personalized medicine … Continue reading Anti Cancer drug: Making it Patient-driven, not Disease-driven
Read more »Food Market making Profit from Climatic Changes
March 14, 2011 - 7:15 am
Categories:
Patent Commercialisation
Pharma- biotech- Patent Commercialisation
0 Comments
Climatic changes being a source of making profit for food crop manufacturers. Adverse changes in climate has triggered the ecosystems affecting crops, livestock, fisheries and forests and the billions of people whose livelihoods depend on them. Extreme climate events (especially hotter, drier conditions in semi-arid regions) are likely to slash yields for maize, wheat, rice … Continue reading Food Market making Profit from Climatic Changes
Read more »INTERNATIONAL PATENT PROTECTION IN ELECTRONICS & IT (SIP-EIT) SCHEME BY DIT
December 16, 2010 - 7:32 am
Categories:
high-tech-patent-commercialisation
Patent Commercialisation
0 Comments
It is enriching to hear and read so much of focus going these days into Innovation at Grass Root and Startup level. With initiatives being taken at all levels by Stakeholders including FICCI, MSME, DIT, and NASSCOM, the next wave of the so called Start-up innovation can really be envisioned. As has correctly been stated … Continue reading INTERNATIONAL PATENT PROTECTION IN ELECTRONICS & IT (SIP-EIT) SCHEME BY DIT
Read more »Hi-tech Patent Licensing Trends
June 14, 2010 - 12:14 pm
Categories:
high-tech-patent-commercialisation
Patent Commercialisation
0 Comments
Ever since Software Patents have got easier to get a grant for, protection of computer readable medium claims on a storable media have enforced the Intellectual Property Rights to a much higher level that a software company can have when compared with the counterpart System and Method claims. Although most countries, unlike US, are still … Continue reading Hi-tech Patent Licensing Trends
Read more »